BVES Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BVES Antibodies for research focused on Blood Vessel Epicardial Substance (BVES) protein. BVES Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BVES plays a vital role in regulating cell adhesion and maintaining endothelial integrity, significantly impacting cardiovascular development and function. Research has shown BVES expression is crucial for proper vascular remodeling. Studies have linked BVES to various pathological conditions, including cardiovascular diseases and cancer. Investigating BVES function continues to reveal potential therapeutic targets for treating these conditions. Advanced research tools enable scientists to explore the molecular mechanisms of BVES and its influence on vascular biology. Understanding BVES pathways helps identify new treatment strategies for vascular disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of cardiovascular biology and disease mechanisms.